BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 26908770)

  • 1. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.
    Brandenburg VM; Kramann R; Rothe H; Kaesler N; Korbiel J; Specht P; Schmitz S; Krüger T; Floege J; Ketteler M
    Nephrol Dial Transplant; 2017 Jan; 32(1):126-132. PubMed ID: 26908770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and risk factors associated with mortality in calcific uremic arteriolopathy.
    Santos PW; He J; Tuffaha A; Wetmore JB
    Int Urol Nephrol; 2017 Dec; 49(12):2247-2256. PubMed ID: 29058165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Australian Calciphylaxis Registry: reporting clinical features and outcomes of patients with calciphylaxis.
    Ruderman I; Toussaint ND; Hawley CM; Krishnasamy R; Pedagogos E; Lioufas N; Elder GJ
    Nephrol Dial Transplant; 2021 Mar; 36(4):649-656. PubMed ID: 31855262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
    Floege J; Kubo Y; Floege A; Chertow GM; Parfrey PS
    Clin J Am Soc Nephrol; 2015 May; 10(5):800-7. PubMed ID: 25887067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet).
    Brandenburg V; Adragao T; van Dam B; Evenepoel P; Frazão JM; Ketteler M; Mazzaferro S; Urena Torres P; Ramos R; Torregrosa JV; Cozzolino M
    Clin Kidney J; 2015 Oct; 8(5):567-71. PubMed ID: 26413282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients - Data from the German Calciphylaxis Registry.
    Rothe H; Brandenburg V; Haun M; Kollerits B; Kronenberg F; Ketteler M; Wanner C
    PLoS One; 2017; 12(2):e0172407. PubMed ID: 28212442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study.
    Gaisne R; Péré M; Menoyo V; Hourmant M; Larmet-Burgeot D
    BMC Nephrol; 2020 Feb; 21(1):63. PubMed ID: 32101140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization, Morphologic Features, and Chemical Composition of Calciphylaxis-Related Skin Deposits in Patients With Calcific Uremic Arteriolopathy.
    Colboc H; Moguelet P; Bazin D; Carvalho P; Dillies AS; Chaby G; Maillard H; Kottler D; Goujon E; Jurus C; Panaye M; Frochot V; Letavernier E; Daudon M; Lucas I; Weil R; Courville P; Monfort JB; Chasset F; Senet P;
    JAMA Dermatol; 2019 Jul; 155(7):789-796. PubMed ID: 31116362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calciphylaxis].
    Brandenburg VM; Martin H; Sohn CM; Ketteler M
    Dtsch Med Wochenschr; 2015 Mar; 140(5):347-51. PubMed ID: 25734678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and treatment modalities in uremic and non uremic calciphylaxis - a dermatological single-center experience.
    Yousuf S; Busch D; Renner R; Schliep S; Erfurt-Berge C
    Ren Fail; 2024 Dec; 46(1):2297566. PubMed ID: 38178572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcific uremic arteriolopathy (Calcyphilaxis): a rare disease? Report of three cases].
    Napolitano P; Capuano A; D'Apice L; Mosella F; Pota A; Saviano C; Russo D
    G Ital Nefrol; 2015; 32(1):. PubMed ID: 25774581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of calcific uraemic arteriolopathy with bisphosphonates.
    Torregrosa JV; Durán CE; Barros X; Blasco M; Arias M; Cases A; Campistol JM
    Nefrologia; 2012 May; 32(3):329-34. PubMed ID: 22592420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distal calcific uremic arteriolopathy in a hemodialysis patient responds to lowering of Ca x P product and aggressive wound care.
    Russell R; Brookshire MA; Zekonis M; Moe SM
    Clin Nephrol; 2002 Sep; 58(3):238-43. PubMed ID: 12356195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calciphylaxis: calcific uraemic arteriolopathy--a case study.
    Byrne H; Lloyd S
    J Ren Care; 2007; 33(2):74-7. PubMed ID: 17702510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calciphylaxis after parathyroidectomy.
    Karmegam S; Shetty A
    Hemodial Int; 2017 Oct; 21 Suppl 2():S62-S66. PubMed ID: 29064176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheopheresis: A new therapeutic approach in severe calciphylaxis.
    Robert T; Lionet A; Bataille S; Seret G
    Nephrology (Carlton); 2020 Apr; 25(4):298-304. PubMed ID: 31576630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calciphylaxis: Beyond CKD-MBD.
    Fernández M; Morales E; Gutierrez E; Polanco N; Hernández E; Mérida E; Praga M
    Nefrologia; 2017; 37(5):501-507. PubMed ID: 28390776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute calciphylaxis precipitated by the initiation of hemodialysis.
    Sandhu G; Casares P; Ranade A; Jones J; Amar LI; Guisado D; Chan G; Smith SD
    Clin Nephrol; 2013 Oct; 80(4):301-5. PubMed ID: 22762780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy.
    Kramann R; Brandenburg VM; Schurgers LJ; Ketteler M; Westphal S; Leisten I; Bovi M; Jahnen-Dechent W; Knüchel R; Floege J; Schneider RK
    Nephrol Dial Transplant; 2013 Apr; 28(4):856-68. PubMed ID: 23223222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calciphylaxis: a rare complication in alcoholic liver disease.
    Sermijn E; Strobbe T; Vandekerckhove L; Libbrecht L; Colle I; Schoonjans R; Vogelaers D
    Acta Clin Belg; 2013; 68(2):116-9. PubMed ID: 23967720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.